{"id":"NCT02086500","sponsor":"Jason Sperry","briefTitle":"Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)","officialTitle":"Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial For Trauma Patients At Risk Of Hemorrhage (STAAMP Trial); Phase III Multicenter, Prospective, Randomized, Double Blind, Interventional Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07","primaryCompletion":"2019-11","completion":"2019-11","firstPosted":"2014-03-13","resultsPosted":"2020-09-10","lastUpdate":"2020-09-10"},"enrollment":903,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Traumatic Hemorrhage"],"interventions":[{"type":"DRUG","name":"Tranexamic Acid","otherNames":[]},{"type":"OTHER","name":"Saline control","otherNames":[]}],"arms":[{"label":"Prehospital Tranexamic Acid","type":"EXPERIMENTAL"},{"label":"Control","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if 1 gram of prehospital tranexamic acid given during emergency medical transport to a level 1 trauma center in patients at risk of hemorrhage is associated with lower 30 day mortality.","primaryOutcome":{"measure":"30 Day Mortality","timeFrame":"30 Day","effectByArm":[{"arm":"Prehospital Tranexamic Acid","deltaMin":36,"sd":null},{"arm":"Control","deltaMin":45,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["38933603","37125811","33016996"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":447},"commonTop":["Pneumothorax","ileus","Seizure","Stroke","Metabolic Acidosis"]}}